EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

miRNA Signatures in Bronchopulmonary Dysplasia: Implications for Biomarkers, Pathogenesis, and Therapeutic Options

Hajime Maeda, Xiaoyun Li, Hayato Go, Phyllis A Dennery, Hongwei Yao

Frontiers in Bioscience-Landmark · 25.07.2024 · 29 (7)

DOI: 10.31083/j.fbl2907271 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 25.07.2024. Verfasst von Hajime Maeda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, Cellular Biology, and Biochemistry, Brown University, Providence, RI 02912, USA. Hauptthemen laut MEDLINE: Bronchopulmonary Dysplasia, MicroRNAs, Biomarkers. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH R01, Rhode Island Foundation grant, Warren Alpert Foundation of Brown University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bronchopulmonary dysplasia (BPD) is a chronic lung disease in premature infants characterized by alveolar dysplasia, vascular simplification and dysmorphic vascular development. Supplemental oxygen and mechanical ventilation commonly used as life-saving measures in premature infants may cause BPD. microRNAs (miRNAs), a class of small, non-coding RNAs, regulate target gene expression mainly through post-transcriptional repression. miRNAs play important roles in modulating oxidative stress, proliferation, apoptosis, senescence, inflammatory responses, and angiogenesis. These cellular processes play pivotal roles in the pathogenesis of BPD. Accumulating evidence demonstrates that miRNAs are dysregulated in the lung of premature infants with BPD, and in animal models of this disease, suggesting contributing roles of dysregulated miRNAs in the development of BPD. Therefore, miRNAs are considered promising biomarker candidates and therapeutic agents for this disease. In this review, we discuss how dysregulated miRNAs and their modulation alter cellular processes involved in BPD. We then focus on therapeutic approaches targeting miRNAs for BPD. This review provides an overview of miRNAs as biomarkers, and highlights potential pathogenic roles, and therapeutic strategies for BPD using miRNAs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bronchopulmonary DysplasiaMicroRNAsBiomarkersHumansInfant, NewbornAnimalsInfant, Premature

Stichwörter der Autor:innen

bronchopulmonary dysplasiahyperoxic exposuremechanical ventilationmicroRNAtherapeutics

Substanzen

MicroRNAsBiomarkers

Autor:innen und Institutionen

  • Department of Molecular Biology, Cellular Biology, and Biochemistry, Brown University, Providence, RI 02912, USA.
  • Department of Pediatrics, Fukushima Medical University School of Medicine, 960-1295 Fukushima, Japan.
  • Providence Veterans Affairs Medical Center, Providence, RI 02908, USA.
  • Department of Medicine, Warren Alpert School of Medicine of Brown University, Providence, RI 02903, USA.
  • College of Pharmacy, Jinan University, 510632 Guangzhou, Guangdong, China.
  • Department of Pediatrics, Warren Alpert School of Medicine of Brown University, Providence, RI 02903, USA.

Förderung

  • NIH R01
  • Rhode Island Foundation grant
  • Warren Alpert Foundation of Brown University
  • NIGMS NIH HHS
  • Institutional Development Award (IDeA) from the NIGMS of NIH
  • NHLBI NIH HHS

Zitieren

APA

Maeda, H., Li, X., Go, H., Dennery, P. A., & Yao, H. (2024). miRNA Signatures in Bronchopulmonary Dysplasia: Implications for Biomarkers, Pathogenesis, and Therapeutic Options. Frontiers in Bioscience-Landmark, 29(7). https://doi.org/10.31083/j.fbl2907271

Vancouver

Maeda H, Li X, Go H, Dennery PA, Yao H. miRNA Signatures in Bronchopulmonary Dysplasia: Implications for Biomarkers, Pathogenesis, and Therapeutic Options. Frontiers in Bioscience-Landmark. 2024;29(7). doi:10.31083/j.fbl2907271

BibTeX
@article{Maeda2024,
  author = {Maeda, Hajime and Li, Xiaoyun and Go, Hayato and Dennery, Phyllis A and Yao, Hongwei},
  title = {miRNA Signatures in Bronchopulmonary Dysplasia: Implications for Biomarkers, Pathogenesis, and Therapeutic Options},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2024},
  volume = {29},
  number = {7},
  doi = {10.31083/j.fbl2907271}
}
Kostenlos starten →